Home / News
-
-
Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, and OhioHealth, a nationally recognized not-for-profit, charitable, integrated health system, today announced a definitive agreement for Quest to acquire select assets of OhioHealth's outreach laboratory services business.2024-07-11View More
-
-
China's respiratory testing market shows significant growth potential, driven by increasing demand, technological advancements, supportive policies, and a growing market size.2024-07-10View More
-
-
Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced that effective today it has acquired Fluent BioSciences, developer of an emerging and highly differentiated single-cell technology.2024-07-10View More
-
-
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received the CE Mark for its Accu-Chek SmartGuide® continuous glucose monitoring (CGM) solution. This significant milestone paves the way for the solution to be made available to people living with type 1 and type 2 diabetes over the age of 18 on flexible insulin therapy.2024-07-10View More
-
-
With the improvement of Chinese manufacturing industry's contribution to the global economy in recent years, more and more international brands, such as Roche, Abbott, Siemens, Beckman, tend to establish the production bases and carry out production in China, to achieve the localization of imported brands. The four giants "Roche, Abbott, Siemens, Beckman" started the localization layout as early as 1985 in China.2024-07-09View More
-
-
Eli Lilly and Company (NYSE: LLY) and Morphic Holding, Inc. (NASDAQ: MORF) today announced a definitive agreement for Lilly to acquire Morphic, a biopharmaceutical company developing oral integrin therapies for treatment of serious chronic diseases.2024-07-09View More
-
-
UK's competition regulator said on Monday it has cleared U.S. medical equipment maker Thermo Fisher Scientific's (TMO.N), opens new tab $3.1 billion deal to buy Swedish biotech firm Olink Holding AB (OLK.O), opens new tab.2024-07-09View More
-
-
Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.2024-07-08View More
-
-
On June 13, 2024, Mindray and Inpeco have officially signed a strategic cooperation agreement at Mindray's headquarters in Shenzhen, China, marking a new era of innovation and collaboration in the in vitro diagnostics industry. This collaboration is founded on the companies¡¯ mutual excellence in their respective fields, as well as their shared values and vision for the future.2024-07-08View More
-
-
Gene Solutions announced Monday that it will partner with the National Cancer Society of Malaysia (NCSM) to expand awareness and enable access to multi-cancer early detection (MCED) testing.2024-07-05View More
-
-
Illumina said on Wednesday that it has signed a research collaboration agreement with the National Cancer Center Singapore (NCCS) to investigate the genomics of a rare cancer in Asians.2024-07-04View More
-
-
Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced a definitive agreement with OMERS to acquire LifeLabs, a trusted provider of community laboratory tests for millions of Canadians, for a value of approximately CAN $1.35 billion (approximately USD $985 million), including net debt.2024-07-03View More
-
-
In 2019-2020, the industry consolidation has driven the "chain reaction" of IVD industry and becomes a mainstream.2024-07-02View More
-
-
Taiwanese cancer genomics firm ACT Genomics (ACTG) and Japanese clinical testing service provider LSI Medience said Monday that they have signed a memorandum of understanding to advance personalized medicine in Japan.2024-07-02View More
-
-
Roche subsidiary Foundation Medicine said Monday that the US Food and Drug Administration has approved its liquid biopsy test, FoundationOne Liquid CDx, as a companion diagnostic to identify advanced BRCA-mutated prostate cancer patients who are eligible for treatment with Janssen's Akeega (niraparib and abiraterone acetate).2024-07-02View More
-
-
Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.2024-07-01View More
-
-
A workgroup convened by the Alzheimer¡¯s Association has published revised criteria for the diagnosis and staging of Alzheimer¡¯s disease that are based on the biology of the disease and reflect recent advancements in Alzheimer¡¯s research, diagnostics and treatment. The 2024 update includes an updated biomarker classification system that includes blood-based biomarkers (BBM) and a revised disease staging system.2024-07-01View More
-
-
Cepheid announced today that it has received FDA De Novo marketing authorization and Clinical Laboratory Improvement Amendments (CLIA) Waiver approval for Xpert® HCV, the only molecular test in the US to detect hepatitis C virus RNA directly from a human capillary whole blood (fingerstick) sample. The Xpert HCV test is performed on the GeneXpert Xpress System.2024-07-01View More
-
-
Mr. Eui-Yul Choi, Chairman of Korea In Vitro Diagnostic Medical Device Association, CEO of Boditech Med, led a delegation to visit China Association of In-Vitro Diagnostics (CAIVD), on 26 June 2024.2024-06-28View More
-
-
Illumina (ILMN.O), opens new tab said on Thursday it will take a goodwill impairment charge of $1.47 billion in the second quarter related to recently spun-off cancer diagnostic test maker Grail (GRAL.O)2024-06-28View More
- CAIVD WeChat
Subscription Account
- CAIVD WeChat
Channels
China Association of In-vitro Diagnostics
Part of the information in our website is from the internet.
If by any chance it violates your rights, please contact us.